Curium Deepens Radiopharma Heft With Up to $8 Billion Deal for Lantheus

3-line summary

• Curium agreed to a deal worth up to $8 billion to acquire Lantheus, deepening its radiopharmaceutical business, according to the report.

This summary is our own processing of the source article; see the source link below for full context.